.Organisation/Company: Fundación Investigación del Cáncer Universidad de SalamancaResearch Field: Biological sciencesResearcher Profile: Recognised Researcher (R2)Positions: PhD PositionsCountry: SpainApplication Deadline: 12 Dec 2024 - 00:00 (Europe/Madrid)Type of Contract: TemporaryJob Status: Full-timeHours Per Week: 35Offer Starting Date: 12 Nov 2024Is the job funded through the EU Research Framework Programme? Not funded by a EU programmeReference Number: 24-15-MTDDOCIs the Job related to staff position within a Research Infrastructure? NoOffer DescriptionRESOLUTION OF THE MANAGING BOARD OF THE CANCER RESEARCH FOUNDATION OF THE UNIVERSITY OF SALAMANCA FOR STAFF RECRUITMENTPosition offered: Ph DoctorCall reference: 24-15-MTDDOCApplication deadline: 30 calendar days from the publication of the call for applications on the website of the FoundationType of contract: Indefinite/ Research LineThe Cancer Research Foundation of the University of Salamanca is a non-profit institution, with its legal personality, private and within the autonomous community of Castile and Leon, subject to general legislation and governed by its statutes and applicable legal provisions, with full capacity to act under the tutelage of its Board of Trustees and whose purpose is to promote and carry out cancer research within the Institute of Molecular and Cellular Biology of Cancer or other applied research organisations.RESOLVESTo convene a selection process for the recruitment of one Ph Doctor, to join the Cancer Research Foundation of the University of Salamanca, located in the Cancer Research Centre of Salamanca, on a competitive basis, with funds available under the project: Proyecto AECC 2024- PRYGN247193DROS -The PEA3 protein family as a therapeutic target for KRAS-mutant lung cancer, whose responsible person is Matthias Drosten, through the recruitment system provided for in the FICUS Staff Recruitment Manual.The selection system shall respect the principles of advertisement, merit, capacity, and free competition of candidates, as well as the principles of speed and efficiency, and shall guarantee, at all times, the transparency of the selection process.EMPLOYMENT CONTRACT CONDITIONS:Line of research: Strategies to overcome resistance to RAS inhibitionForeseen start date: January 2024Professional category: Ph DoctorTimetable: Full time, 35 h/weekFunding: Proyecto AECC 2024- PRYGN247193DROS -The PEA3 protein family as a therapeutic target for KRAS-mutant lung cancerThe signing of the contract will be subject to the successful candidate's compliance with the requirements of current employment legislation. In case of non-compliance with the requirements, the next candidate will be contacted in ranking order.DUTIES:The person hired will join the 7 laboratory- Matthias Drosten